Fresenius | FRE - Ativos





Ativos Alterar Data
Akzo Nobel EUR 16.13B 647M 2026-06
Alcon AG USD 31.62B 64M 2026-03
AstraZeneca USD 115.83B 1.82B 2026-06
BASF EUR 83.87B 2.1B 2026-06
Bayer EUR 107.94B 3.4B 2026-03
Beiersdorf EUR 12.76B 166M 2025-12
DaVita Healthcare Partners USD 17.71B 210.12M 2026-06
Demant DKK 39.07B 6.43B 2025-12
E.ON EUR 117.22B 6.53B 2026-03
Essilor EUR 65.06B 1.16B 2026-06
Fresenius EUR 42.37B 975M 2026-03
Fresenius Medical Care EUR 31.47B 465.26M 2026-03
Getinge SEK 57.37B 6.55B 2026-06
Givaudan CHF 11.86B 587M 2025-12
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
GN Store Nord DKK 28.56B 671M 2026-03
GRIFOLS EUR 20.09B 12M 2026-06
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Lonza CHF 18.97B 164M 2025-12
Merck EUR 53.07B 1.54B 2026-03
Novartis USD 122.03B 3.5B 2026-06
Philips EUR 26.7B 565M 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
RWE EUR 116.76B 15.05B 2026-03
Sanofi EUR 129.06B 1.04B 2026-06
Smith & Nephew USD 11.01B 321M 2026-06